Board of Directors

Dr. William Garner, MD

Chairman of the Board of Director

Dr. Garner is the founder of EGB Advisors PR LLC, a pharmaceutical commercialization boutique, where he has focused on advancing technologies and companies to significant value inflection points leading to monetization of

Learn More

Martin Bott, MIBS

Director

Mr. Bott brings over 28 years’ experience in senior financial and executive leadership to InMed’s Board of Directors. He currently serves as V.P. of Corporate Finance and Investment Banking at Eli Lilly & Company. Mr. Bott joined

Learn More

Adam Cutler

Director

Mr. Cutler brings more than 20 years of experience in the global healthcare industry where he has held senior leadership positions in equity research, corporate finance, business development and management consulting. Mr.

Learn More

Andrew Hull, BA

Director

Mr. Hull has over 30 years’ experience in various commercial and business development roles with leading pharmaceutical and biotech companies. He most recently served as Vice President of Global Alliances for Takeda

Learn More

Eric A. Adams, MIBS

Chief Executive Officer & President

Eric A. Adams was appointed Chief Executive Officer, President and Director of InMed Pharmaceuticals, Inc. in June 2016. During his tenure at InMed, he has reconstituted the Board of Directors and the Executive management

Learn More